HepQuant Llc - Product Pipeline Analysis, 2018 Update

HepQuant Llc - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME215415PD
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Hepquant LLC (Hepquant) is a medical device company that offers diagnostic products. The company develops and markets patented and patent-pending technology for assessing liver function of patients with chronic liver disease. It offers investigational combination drug and diagnostic devices. Hepquant offers services including consultative services that provide analysis and assessments of research applications of HepQuant tests; lab services that process and analyse serum samples; and modeling and reporting services that analysis data and relationship to utility and outcomes. The company provides liver testing support services to liver research centers and pharmaceutical companies. Hepquant is headquartered in Greenwood, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company HepQuant Llc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

HepQuant Llc Company Overview 4

HepQuant Llc Company Snapshot 4

HepQuant Llc Pipeline Products and Ongoing Clinical Trials Overview 4

HepQuant Llc-Pipeline Analysis Overview 6

HepQuant Llc-Key Facts 6

HepQuant Llc-Major Products and Services 7

HepQuant Llc Pipeline Products by Development Stage 8

HepQuant Llc Ongoing Clinical Trials by Trial Status 9

HepQuant Llc Pipeline Products Overview 11

HepQuant-Dual 11

HepQuant-Dual Product Overview 11

HepQuant-FLOW 12

HepQuant-FLOW Product Overview 12

HepQuant-SHUNT 13

HepQuant-SHUNT Product Overview 13

HepQuant-SHUNT Clinical Trial 14

HepQuant-STAT 15

HepQuant-STAT Product Overview 15

HepQuant Llc-Key Competitors 16

HepQuant Llc-Key Employees 17

HepQuant Llc-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

HepQuant Llc, Recent Developments 19

Mar 06, 2018: HepQuant Appoints Richard Whitcomb As Chief Operating Officer 19

Jan 25, 2018: HepQuant and CTI Clinical Trial and Consulting Services Announce First Patient Enrolled in Liver Disease Diagnostic Trial 19

Oct 31, 2017: HepQuant Makes Change to Regulatory Team 20

Sep 28, 2017: HepQuant to Sponsor its First Clinical Study 20

Sep 14, 2017: HepQuant Announces Approval of Fourth Investigational Device Exemption Application 21

Mar 17, 2017: HepQuant Announces Approval of Second Investigational Device Exemption Application 21

Mar 09, 2017: HepQuantAnnounces Approval of First Investigational Device Exemption Application 21

Feb 11, 2016: HepQuant Receives OEDIT Grant 21

Feb 22, 2012: HepQuant to Begin Clinical Study of Liver Function Measurement Tests 22

Feb 09, 2011: HepQuant Proceeding with Three Noninvasive Tests of Liver Function 22

Appendix 24

Methodology 24

About GlobalData 27

Contact Us 27

Disclaimer 27

List of Figures

HepQuant Llc Pipeline Products by Equipment Type 5

HepQuant Llc Pipeline Products by Development Stage 8

HepQuant Llc Ongoing Clinical Trials by Trial Status 9

List of Tables

HepQuant Llc Pipeline Products and Ongoing Clinical Trials Overview 4

HepQuant Llc Pipeline Products by Equipment Type 5

HepQuant Llc Pipeline Products by Indication 5

HepQuant Llc Ongoing Clinical Trials by Trial Status 5

HepQuant Llc, Key Facts 6

HepQuant Llc, Major Products and Services 7

HepQuant Llc Number of Pipeline Products by Development Stage 8

HepQuant Llc Pipeline Products Summary by Development Stage 8

HepQuant Llc Ongoing Clinical Trials by Trial Status 9

HepQuant Llc Ongoing Clinical Trials Summary 10

HepQuant-Dual-Product Status 11

HepQuant-Dual-Product Description 11

HepQuant-FLOW-Product Status 12

HepQuant-FLOW-Product Description 12

HepQuant-SHUNT-Product Status 13

HepQuant-SHUNT-Product Description 13

HepQuant-SHUNT-Intra-individual Reproducibility of the Non-invasive Assessment of the Portal Circulation 14

HepQuant-SHUNT-The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology 14

HepQuant-STAT-Product Status 15

HepQuant-STAT-Product Description 15

HepQuant Llc, Key Employees 17

Glossary 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

GeneTex Inc

Biowave Corp

Diazyme Laboratories Inc

HepQuant Llc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 52500
Site License
USD 1500 INR 105000
Corporate User License
USD 2250 INR 157500



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com